Showing results (61-70 of 214) with videos related to
Sort By:
Pageof 22
Cancer Chemotherapy and Pharmacology|January 1, 1981
Pharmacokinetics of daunorubicin after administration as free drug or as DNA complex in leukemic patientsS O Nilsson, B Andersson, S Eksborg, et al.Leukemia Research|January 1, 1986
Induction of differentiation in human myeloid leukemia cells with cytosine arabinosideM Beran, W N Hittelman, B S Andersson, et al.Blood|August 1, 1988
Antileukemic effect of recombinant tumor necrosis factor alpha in vitro and its modulation by alpha and gamma interferonsM Beran, K B McCredie, M J Keating, et al.Current Medical Research and Opinion|January 1, 1990
Changes in asthmatic patients' symptoms and lifestyles on institution of inhaled budesonide therapyJ N Nankani, M Northfield, Y M Beran, et al.Cancer Research|August 1, 1992
CI-973, a new platinum derivative with potential antileukemic activityS O'Brien, H Kantarjian, E Freireich, et al.Cancer Research|March 15, 1996
Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cellsS Jeha, X N Luo, M Beran, et al.Cancer Research|January 15, 1988
The effects of acetaldophosphamide, a novel stable aldophosphamide analogue, on normal human and leukemic progenitor cells in vitro: implications for use in bone marrow purgingM Beran, B S Andersson, Y Wang, et al.Folia Microbiologica|January 1, 1990
Preparative high-performance liquid chromatography of minor products of Streptomyces cinnamonensisM Beran, J Nĕmecek, J Tax, et al.Hematologic Pathology|January 1, 1988
Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cellsM Beran, S O'Brien, B Andersson, et al.Hematologic Pathology|January 1, 1988
Lack of breakpoint cluster region rearrangement in marrow fibroblasts of patients with Philadelphia chromosome-positive chronic myelogenous leukemiaS O'Brien, H Kantarjian, M Shtalrid, et al.Pageof 22